Cargando…
Intrabronchial Valve Treatment for Prolonged Air Leak: Can We Justify the Cost?
Background. Prolonged air leak is defined as an ongoing air leak for more than 5 days. Intrabronchial valve (IBV) treatment is approved for the treatment of air leaks. Objective. To analyze our experience with IBV and valuate its cost-effectiveness. Methods. Retrospective analysis of IBV from June 2...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904513/ https://www.ncbi.nlm.nih.gov/pubmed/27445523 http://dx.doi.org/10.1155/2016/2867547 |
_version_ | 1782437154498019328 |
---|---|
author | Podgaetz, Eitan Zamora, Felix Gibson, Heidi Andrade, Rafael S. Hall, Eric Dincer, H. Erhan |
author_facet | Podgaetz, Eitan Zamora, Felix Gibson, Heidi Andrade, Rafael S. Hall, Eric Dincer, H. Erhan |
author_sort | Podgaetz, Eitan |
collection | PubMed |
description | Background. Prolonged air leak is defined as an ongoing air leak for more than 5 days. Intrabronchial valve (IBV) treatment is approved for the treatment of air leaks. Objective. To analyze our experience with IBV and valuate its cost-effectiveness. Methods. Retrospective analysis of IBV from June 2013 to October 2014. We analyzed direct costs based on hospital and operating room charges. We used average costs in US dollars for the analysis not individual patient data. Results. We treated 13 patients (9 M/4 F), median age of 60 years (38 to 90). Median time from diagnosis to IBV placement was 9.8 days, time from IBV placement to chest tube removal was 3 days, and time from IBV placement to hospital discharge was 4 days. Average room and board costs were $14,605 including all levels of care. IBV cost is $2750 per valve. The average number of valves used was 4. Total cost of procedure, valves, and hospital stay until discharge was $13,900. Conclusion. In our limited experience, the use of IBV to treat prolonged air leaks is safe and appears cost-effective. In pure financial terms, the cost seems justified for any air leak predicted to last greater than 8 days. |
format | Online Article Text |
id | pubmed-4904513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-49045132016-06-30 Intrabronchial Valve Treatment for Prolonged Air Leak: Can We Justify the Cost? Podgaetz, Eitan Zamora, Felix Gibson, Heidi Andrade, Rafael S. Hall, Eric Dincer, H. Erhan Can Respir J Research Article Background. Prolonged air leak is defined as an ongoing air leak for more than 5 days. Intrabronchial valve (IBV) treatment is approved for the treatment of air leaks. Objective. To analyze our experience with IBV and valuate its cost-effectiveness. Methods. Retrospective analysis of IBV from June 2013 to October 2014. We analyzed direct costs based on hospital and operating room charges. We used average costs in US dollars for the analysis not individual patient data. Results. We treated 13 patients (9 M/4 F), median age of 60 years (38 to 90). Median time from diagnosis to IBV placement was 9.8 days, time from IBV placement to chest tube removal was 3 days, and time from IBV placement to hospital discharge was 4 days. Average room and board costs were $14,605 including all levels of care. IBV cost is $2750 per valve. The average number of valves used was 4. Total cost of procedure, valves, and hospital stay until discharge was $13,900. Conclusion. In our limited experience, the use of IBV to treat prolonged air leaks is safe and appears cost-effective. In pure financial terms, the cost seems justified for any air leak predicted to last greater than 8 days. Hindawi Publishing Corporation 2016 2016-04-04 /pmc/articles/PMC4904513/ /pubmed/27445523 http://dx.doi.org/10.1155/2016/2867547 Text en Copyright © 2016 Eitan Podgaetz et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Podgaetz, Eitan Zamora, Felix Gibson, Heidi Andrade, Rafael S. Hall, Eric Dincer, H. Erhan Intrabronchial Valve Treatment for Prolonged Air Leak: Can We Justify the Cost? |
title | Intrabronchial Valve Treatment for Prolonged Air Leak: Can We Justify the Cost? |
title_full | Intrabronchial Valve Treatment for Prolonged Air Leak: Can We Justify the Cost? |
title_fullStr | Intrabronchial Valve Treatment for Prolonged Air Leak: Can We Justify the Cost? |
title_full_unstemmed | Intrabronchial Valve Treatment for Prolonged Air Leak: Can We Justify the Cost? |
title_short | Intrabronchial Valve Treatment for Prolonged Air Leak: Can We Justify the Cost? |
title_sort | intrabronchial valve treatment for prolonged air leak: can we justify the cost? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904513/ https://www.ncbi.nlm.nih.gov/pubmed/27445523 http://dx.doi.org/10.1155/2016/2867547 |
work_keys_str_mv | AT podgaetzeitan intrabronchialvalvetreatmentforprolongedairleakcanwejustifythecost AT zamorafelix intrabronchialvalvetreatmentforprolongedairleakcanwejustifythecost AT gibsonheidi intrabronchialvalvetreatmentforprolongedairleakcanwejustifythecost AT andraderafaels intrabronchialvalvetreatmentforprolongedairleakcanwejustifythecost AT halleric intrabronchialvalvetreatmentforprolongedairleakcanwejustifythecost AT dincerherhan intrabronchialvalvetreatmentforprolongedairleakcanwejustifythecost |